Global News

Gorilla raised $232 million across two financings to support AI infrastructure projects in Indonesia and India.

A separate pediatric study delivered “striking” WT1 vaccine results, supporting GPS’s scientific rationale, the company's CEO said.

Former Tesla President Jon McNeill said the Roadster may hover using SpaceX-developed cold-gas thrusters.

Nio’s third-generation ES8 is expected to reach 140,000 cumulative deliveries this week.

Dow futures were down 0.03%, while the S&P 500 futures fell 0.25% and the Nasdaq-100 futures slumped 0.60% at 10:54 PM EDT.

CEO Andrew Dudum marked the company’s fifth listing anniversary by ringing the NYSE opening bell and declaring its “next phase of growth.”

The underlying agreement could give AST rights to as much as 45 MHz of spectrum for more than 80 years.

As passage of oil through the Strait of Hormuz remains shrouded in uncertainty, the world's largest oil companies are stocking up their cash reserves, according to The Kobeissi Letter.

The total includes $1.2 trillion in unstarted leases and $1.9 trillion in purchase commitments.

Goldman increased its stake in Sellas by 5.2% to 585,035 shares, worth $8.64 million.

Mizuho said Grok 4.6 is “roughly in line” with newer OpenAI and Anthropic models, with its performance, pricing and Cursor distribution supporting enterprise gains.

JANA Partners Management now holds about 3.66 million FISV shares worth nearly $180 million as of the second quarter, down from 4.44 million shares worth about $247.5 million in the previous quarter.

Oscar Health CEO Mark Bertolini identified uncovered GLP-1 drugs as a potential use case for Hims on the marketplace.

Nio could reach breakeven in 2027 with $348 million in net profit, but Morningstar expects cash burn to persist for “at least a couple more years.”

Dow futures were down 0.09%, while the S&P 500 futures climbed 0.09% and the Nasdaq-100 futures were up 0.25% at the time of writing.

Upcoming catalysts include Golden Dome work, a 2027 lunar mission and NASA’s estimated $10 billion-plus CLPS 2.0 program.

The satellites will support Globalstar’s direct-to-device communications and IoT services.

The European Medicines Agency validated the marketing authorization application for Valneva’s Lyme disease vaccine, which it developed with Pfizer

Burry believes CoreWeave’s limited float, retail popularity, and short-squeeze potential make it too dangerous to bet against.

The UBS purchase reversed a sharp Q1 decline, though its holdings remain far below their early-2025 peak.

Dow futures were up 0.09%, S&P 500 futures climbed 0.04% and Nasdaq-100 futures declined 0.08% at the time of writing.

The company plans to double its quarterly equipment production capacity by 2028.

Vanguard held SLS and IBRX positions worth a combined $259 million at quarter-end.

Rocket Lab secured a $12 million Space Force award set for an orbital data network.

Some vesting targets involve multitrillion-dollar valuations, space-based computing and a million-person Mars settlement.

Musk is targeting 100 gigawatts of annual U.S. solar production, over 300x Tesla’s current Buffalo capacity.

The founder and CEO of Pershing Square Capital Management has said that the hedge fund has picked up a new stake in Netflix in the latest quarter.

Nio has added only 341 stations toward its 1,000-plus target for 2026, with about 450 openings expected in Q4.

Companies controlling launch and orbital infrastructure could capture “disproportionate value,” the research firm said.

U.S. July CPI broadly met expectations, with headline inflation rising 0.1% month over month and 3.4% year over year, while core CPI increased 0.2% monthly and 2.5% annually.

Morningstar maintained its $62 fair-value estimate, implying about 58% downside, and rates SPCX stock one star.

Analyst Tim Farrar said Rocket Lab may be better shielded from SpaceX, while AST faces direct competition from Starlink.

Alliance Global lifted its SLS price target to $35 from $25, implying nearly 200% upside, and maintained a ‘Buy’ rating.

Neutron remains on track for Q4 pad delivery, but its year-end launch window is narrowing.

ASTS said carriers “want the service now,” prompting AST SpaceMobile to push hard for a rapid rollout.

AMD expects Helios to generate billions of dollars in its first full quarter and its AI business to more than double in 2027.

Older models struggled, with ES6 deliveries falling 28% and several sedans recording minimal sales.

ARK Invest bought 292,873 Rocket Lab shares worth about $23.43 million across ARKK, ARKQ and ARKX as the stock weakened.

Musk also said AI revenue could surpass SpaceX’s core businesses by September.

Morningstar’s $23 fair value implies a 25% downside, with a 'Very High Uncertainty' rating.

Marathon Petroleum and Phillips 66 shares gained more than 3% each on Tuesday, helped by higher crude prices, while PSX stock also rose after finalizing a JV agreement for a $5 billion pipeline.

Curaleaf announced a cash-and-stock offer that represents a 45% premium to Aurora’s 30-day volume-weighted average price.

Wall Street expects no quarterly revenue and a GAAP loss of $0.04 per share, narrowing from $0.05 previously.

Baron Capital’s $3 billion SpaceX investment was worth about $25 billion in June, and the firm wants to invest another $1 billion.

BlackRock also trimmed XPeng, while increasing its Lucid and Rivian holdings to record levels.

ARK considers the China issue a manageable “small-ish wrinkle” that could be addressed by ring-fencing the assets.

U.S. President Donald Trump said on Monday that he would seek compensation from Iran as part of any peace agreement.

Hims called Wegovy pill demand “staggering” and plans new testosterone and peptide treatments.

AST SpaceMobile booked 10 launches as BlueBird production advances through satellite 46.

The company reported “absolutely zero issues” selling pre-flight Neutron missions at their full $50 million to $55 million price.